SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000929638-24-000716
Filing Date
2024-02-14
Accepted
2024-02-14 16:54:45
Documents
2
Group Members
TYBOURNE CAPITAL MANAGEMENT LTDTYBOURNE KESARI LTDTYBOURNE STRATEGIC OPPORTUNITIES GP II LTDVISWANATHAN KRISHNAN

Document Format Files

Seq Description Document Type Size
1 sch13g.htm SC 13G 102271
2 exhibit99-1.htm EX-99.1 9208
  Complete submission text file 0000929638-24-000716.txt   113536
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Subject) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89959 | Film No.: 24639888
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SUITES 1021-25, 10/F, CHAMPION TOWER 3 GARDEN ROAD, CENTRAL HONG KONG K3 XXXXX
Business Address SUITES 1021-25, 10/F, CHAMPION TOWER 3 GARDEN ROAD, CENTRAL HONG KONG K3 XXXXX 852-3983-6800
TYBOURNE CAPITAL MANAGEMENT (HK) LTD (Filed by) CIK: 0001553936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: K3 | Fiscal Year End: 1231
Type: SC 13G